LRA 5Р advanced adenoma is an important risk factor for finding No adenoma 10Р advanced adenoma at the next examination. Once pa- HRA HRA 3Р tients have a low-risk lesion or no adenoma, the risk of LRA 5Р aР advanced neoplasia at the next examination is lower. Pa- No adenoma 5Р tients with LRA at baseline and no adenomas at first aIf the findings on the second surveillance are negative, there isР surveillance have a very low risk (2.8%–4.9%) of having insufficient evidence to make a recommendation.